Cyclooxygenase-2 prostaglandins mediate anandamide-inhibitory action on nitric oxide synthase activity in the receptive rat uterus.

European journal of pharmacology 20120615

Rational design, synthesis and anti-proliferative properties of new CB2 selective cannabinoid receptor ligands: an investigation of the 1,8-naphthyridin-2(1H)-one scaffold.

European journal of medicinal chemistry 20120601

AM630 behaves as a protean ligand at the human cannabinoid CB2 receptor.

British journal of pharmacology 20120401

Activation of cannabinoid receptor 2 attenuates leukocyte-endothelial cell interactions and blood-brain barrier dysfunction under inflammatory conditions.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20120321

The effects of cannabinoid CB1, CB2 and vanilloid TRPV1 receptor antagonists on cocaine addictive behavior in rats.

Brain research 20120320

Sex differences in cannabinoid 1 vs. cannabinoid 2 receptor-selective antagonism of antinociception produced by delta9-tetrahydrocannabinol and CP55,940 in the rat.

The Journal of pharmacology and experimental therapeutics 20120301

3-Substituted pyrazole analogs of the cannabinoid type 1 (CB₁) receptor antagonist rimonabant: cannabinoid agonist-like effects in mice via non-CB₁, non-CB₂ mechanism.

The Journal of pharmacology and experimental therapeutics 20120201

CB2 cannabinoid receptors promote neural progenitor cell proliferation via mTORC1 signaling.

The Journal of biological chemistry 20120106

Expression of fatty acid amide hydrolase (FAAH) in human, mouse, and rat urinary bladder and effects of FAAH inhibition on bladder function in awake rats.

European urology 20120101

Cloning and pharmacological characterization of the dog cannabinoid CB₂receptor.

European journal of pharmacology 20111101

Fatty acid amide hydrolase blockade attenuates the development of collagen-induced arthritis and related thermal hyperalgesia in mice.

Pharmacology, biochemistry, and behavior 20111001

Antinociceptive effects induced through the stimulation of spinal cannabinoid type 2 receptors in chronically inflamed mice.

European journal of pharmacology 20111001

Mutagenesis and computer modeling studies of a GPCR conserved residue W5.43(194) in ligand recognition and signal transduction for CB2 receptor.

International immunopharmacology 20110901

Investigations on the 4-quinolone-3-carboxylic acid motif. 4. Identification of new potent and selective ligands for the cannabinoid type 2 receptor with diverse substitution patterns and antihyperalgesic effects in mice.

Journal of medicinal chemistry 20110811

Cannabinoid potentiation of glycine receptors contributes to cannabis-induced analgesia.

Nature chemical biology 20110501

The hypothermic response to bacterial lipopolysaccharide critically depends on brain CB1, but not CB2 or TRPV1, receptors.

The Journal of physiology 20110501

Endocannabinoid 2-arachidonoylglycerol protects neurons against β-amyloid insults.

Neuroscience 20110331

Effects of cannabinoid agonists on sheep sphincter of oddi in vitro.

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] 20110101

Energetic metabolism and human sperm motility: impact of CB₁ receptor activation.

Endocrinology 20101201

Cannabinoid receptor activation leads to massive mobilization of myeloid-derived suppressor cells with potent immunosuppressive properties.

European journal of immunology 20101201

Pharmacological evaluation of the natural constituent of Cannabis sativa, cannabichromene and its modulation by Δ(9)-tetrahydrocannabinol.

Drug and alcohol dependence 20101101

Human platelets express authentic CB₁ and CB₂ receptors.

Current neurovascular research 20101101

Effects of abnormal cannabidiol on oxytocin-induced myometrial contractility.

Reproduction (Cambridge, England) 20100401

Endocannabinoid regulation of spinal nociceptive processing in a model of neuropathic pain.

The European journal of neuroscience 20100401

Antinociceptive effect of the cannabinoid agonist, WIN 55,212-2, in the orofacial and temporomandibular formalin tests.

European journal of pain (London, England) 20100101

Anandamide suppresses proliferation and cytokine release from primary human T-lymphocytes mainly via CB2 receptors.

PloS one 20100101

The cannabinoid receptor agonist WIN 55,212-2 inhibits antigen-induced plasma extravasation in guinea pig airways.

International archives of allergy and immunology 20100101

Echinacea-induced cytosolic Ca2+ elevation in HEK293.

BMC complementary and alternative medicine 20100101

Signaling pathways from cannabinoid receptor-1 activation to inhibition of N-methyl-D-aspartic acid mediated calcium influx and neurotoxicity in dorsal root ganglion neurons.

The Journal of pharmacology and experimental therapeutics 20091201

The cannabinoid R+ methanandamide induces IL-6 secretion by prostate cancer PC3 cells.

Journal of immunotoxicology 20091201

Evaluation of prevalent phytocannabinoids in the acetic acid model of visceral nociception.

Drug and alcohol dependence 20091101

The endocannabinoid transport inhibitor AM404 modulates nociception in cholestasis.

Neuroscience letters 20091025

Cannabinoid CB2 receptor agonists protect the striatum against malonate toxicity: relevance for Huntington's disease.

Glia 20090815

Regulation and possible role of endocannabinoids and related mediators in hypercholesterolemic mice with atherosclerosis.

Atherosclerosis 20090801

AM-251 and SR144528 are acyl CoA:cholesterol acyltransferase inhibitors.

Biochemical and biophysical research communications 20090403

The endocannabinoid system in bull sperm and bovine oviductal epithelium: role of anandamide in sperm-oviduct interaction.

Reproduction (Cambridge, England) 20090301

A CB(2) receptor agonist, A-836339, modulates wide dynamic range neuronal activity in neuropathic rats: contributions of spinal and peripheral CB(2) receptors.

Neuroscience 20090218

Characterization of a cannabinoid CB2 receptor-selective agonist, A-836339 [2,2,3,3-tetramethyl-cyclopropanecarboxylic acid [3-(2-methoxy-ethyl)-4,5-dimethyl-3H-thiazol-(2Z)-ylidene]-amide], using in vitro pharmacological assays, in vivo pain models, and pharmacological magnetic resonance imaging.

The Journal of pharmacology and experimental therapeutics 20090101

Activation of cannabinoid receptors prevents antigen-induced asthma-like reaction in guinea pigs.

Journal of cellular and molecular medicine 20081201

CB(2) cannabinoid receptor antagonist SR144528 decreases mu-opioid receptor expression and activation in mouse brainstem: role of CB(2) receptor in pain.

Neurochemistry international 20081201

Selective activation of cannabinoid CB2 receptors suppresses neuropathic nociception induced by treatment with the chemotherapeutic agent paclitaxel in rats.

The Journal of pharmacology and experimental therapeutics 20081101

N-arachidonylethanolamide-induced increase in aqueous humor outflow facility.

Investigative ophthalmology & visual science 20081001

Aqueous humor outflow effects of 2-arachidonylglycerol.

Experimental eye research 20080801

Discriminative stimulus effects of the cannabinoid CB1 receptor antagonist rimonabant in rats.

Psychopharmacology 20080701

The cannabinoid delta-9-tetrahydrocannabinol mediates inhibition of macrophage chemotaxis to RANTES/CCL5: linkage to the CB2 receptor.

Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology 20080601

First in vivo evidence for a functional interaction between chemokine and cannabinoid systems in the brain.

The Journal of pharmacology and experimental therapeutics 20080501

A saturated N-acylethanolamine other than N-palmitoyl ethanolamine with anti-inflammatory properties: a neglected story..

Journal of neuroendocrinology 20080501

Cannabinoid receptor 2 (CB2) mediates immunoglobulin class switching from IgM to IgE in cultures of murine-purified B lymphocytes.

Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology 20080301

Topical WIN55212-2 alleviates intraocular hypertension in rats through a CB1 receptor mediated mechanism of action.

Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20080201

Pharmacological evaluation of a novel cannabinoid 2 (CB2) ligand, PF-03550096, in vitro and in vivo by using a rat model of visceral hypersensitivity.

Journal of pharmacological sciences 20080201

Actions of N-arachidonyl-glycine in a rat neuropathic pain model.

Neuropharmacology 20080101

[Role of cannabinoid receptors in regulation of cardiac tolerance to ischemia and reperfusion].

Izvestiia Akademii nauk. Seriia biologicheskaia 20080101

Cannabinoid CB(2) receptor activation prevents bronchoconstriction and airway oedema in a model of gastro-oesophageal reflux.

European journal of pharmacology 20071114

Activation of cannabinoid CB1 and CB2 receptors suppresses neuropathic nociception evoked by the chemotherapeutic agent vincristine in rats.

British journal of pharmacology 20071101

Cannabinoids inhibit noradrenergic and purinergic sympathetic cotransmission in the rat isolated mesenteric arterial bed.

British journal of pharmacology 20071101

The endogenous cannabinoid anandamide inhibits cromakalim-activated K+ currents in follicle-enclosed Xenopus oocytes.

The Journal of pharmacology and experimental therapeutics 20071101

The inhibition of monoacylglycerol lipase by URB602 showed an anti-inflammatory and anti-nociceptive effect in a murine model of acute inflammation.

British journal of pharmacology 20071101

Characterization of the vasorelaxant mechanisms of the endocannabinoid anandamide in rat aorta.

British journal of pharmacology 20071101

The antinociceptive effect of Delta9-tetrahydrocannabinol in the arthritic rat involves the CB(2) cannabinoid receptor.

European journal of pharmacology 20070910

Anandamide and Delta9-tetrahydrocannabinol directly inhibit cells of the immune system via CB2 receptors.

Journal of neuroimmunology 20070901

The effect of the palmitoylethanolamide analogue, palmitoylallylamide (L-29) on pain behaviour in rodent models of neuropathy.

British journal of pharmacology 20070801

Virodhamine and CP55,940 modulate cAMP production and IL-8 release in human bronchial epithelial cells.

British journal of pharmacology 20070801

2-Arachidonoylglycerol enhances the phagocytosis of opsonized zymosan by HL-60 cells differentiated into macrophage-like cells.

Biological & pharmaceutical bulletin 20070701

Attenuation of allergic contact dermatitis through the endocannabinoid system.

Science (New York, N.Y.) 20070608

Anandamide-mediated CB1/CB2 cannabinoid receptor--independent nitric oxide production in rabbit aortic endothelial cells.

The Journal of pharmacology and experimental therapeutics 20070601

Depolarization-induced rapid generation of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, in rat brain synaptosomes.

Journal of biochemistry 20070501

A novel role of cannabinoids: implication in the fever induced by bacterial lipopolysaccharide.

The Journal of pharmacology and experimental therapeutics 20070301

Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro.

British journal of pharmacology 20070301

CB2 cannabinoid receptors promote mouse neural stem cell proliferation.

The European journal of neuroscience 20070201

Involvement of cannabinoid CB2 receptors in the IgE-mediated triphasic cutaneous reaction in mice.

Life sciences 20070109

CB1 receptor activation in the basolateral amygdala produces antinociception in animal models of acute and tonic nociception.

Clinical and experimental pharmacology & physiology 20070101

Involvement of the cannabinoid CB2 receptor and its endogenous ligand 2-arachidonoylglycerol in oxazolone-induced contact dermatitis in mice.

Journal of immunology (Baltimore, Md. : 1950) 20061215

Characterization of cannabinoid agonists and apparent pA2 analysis of cannabinoid antagonists in rhesus monkeys discriminating Delta9-tetrahydrocannabinol.

The Journal of pharmacology and experimental therapeutics 20061201

Effects of a cannabinoid agonist on spinal nociceptive neurons in a rodent model of neuropathic pain.

Journal of neurophysiology 20061201

In vivo modulation of LPS-induced alterations in brain and peripheral cytokines and HPA axis activity by cannabinoids.

Journal of neuroimmunology 20061201

Role of cannabinoid receptors in the regulation of cardiac contractility during ischemia/reperfusion.

Bulletin of experimental biology and medicine 20061101

Involvement of cannabinoid receptors in inflammatory hypersensitivity to colonic distension in rats.

Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society 20061001

Non-cannabinoid CB1, non-cannabinoid CB2 antinociceptive effects of several novel compounds in the PPQ stretch test in mice.

European journal of pharmacology 20060928

Evaluation of the role of nicotinic acetylcholine receptor subtypes and cannabinoid system in the discriminative stimulus effects of nicotine in rats.

European journal of pharmacology 20060701

Delta9-tetrahydrocannabinol inhibits cell cycle progression in human breast cancer cells through Cdc2 regulation.

Cancer research 20060701

Cannabinoids induce apoptosis of pancreatic tumor cells via endoplasmic reticulum stress-related genes.

Cancer research 20060701

2-Arachidonylglycerol acting on CB1 cannabinoid receptors mediates delayed cardioprotection induced by nitric oxide in rat isolated hearts.

Journal of cardiovascular pharmacology 20060501

[Paticipation of cannabinoid receptors in the regulation of cardiac rhythm and cardiac contractility].

Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova 20060401

Synthesis and SAR studies of 2-oxoquinoline derivatives as CB2 receptor inverse agonists.

Journal of medicinal chemistry 20060323

A novel cannabinoid peripheral cannabinoid receptor-selective inverse agonist blocks leukocyte recruitment in vivo.

The Journal of pharmacology and experimental therapeutics 20060201

Antagonism of discriminative stimulus effects of delta(9)-THC and (R)-methanandamide in rats.

Psychopharmacology 20060101

Cannabinoid receptor agonists inhibit Ca(2+) influx to synaptosomes from rat brain.

Pharmacology 20060101

Methods evaluating cannabinoid and endocannabinoid effects on gastrointestinal functions.

Methods in molecular medicine 20060101

Capsaicin evokes hypothermia independent of cannabinoid CB1 and CB2 receptors.

Brain research 20051214

Inhibitors of fatty acid amide hydrolase reduce carrageenan-induced hind paw inflammation in pentobarbital-treated mice: comparison with indomethacin and possible involvement of cannabinoid receptors.

British journal of pharmacology 20051001

Involvement of cannabinoid CB(2) receptor-mediated response and efficacy of cannabinoid CB(2) receptor inverse agonist, JTE-907, in cutaneous inflammation in mice.

European journal of pharmacology 20050927

Endogenous cannabinoid receptor agonists inhibit neurogenic inflammations in guinea pig airways.

International archives of allergy and immunology 20050901

Inhibitory effects of CB1 and CB2 receptor agonists on responses of DRG neurons and dorsal horn neurons in neuropathic rats.

The European journal of neuroscience 20050701

Anti-inflammatory potential of CB1-mediated cAMP elevation in mast cells.

The Biochemical journal 20050601

Activation of cannabinoid CB2 receptor negatively regulates IL-12p40 production in murine macrophages: role of IL-10 and ERK1/2 kinase signaling.

British journal of pharmacology 20050601

Peripheral, but not central effects of cannabidiol derivatives: mediation by CB(1) and unidentified receptors.

Neuropharmacology 20050601

Evidence for the involvement of the cannabinoid CB2 receptor and its endogenous ligand 2-arachidonoylglycerol in 12-O-tetradecanoylphorbol-13-acetate-induced acute inflammation in mouse ear.

The Journal of biological chemistry 20050506

Cannabinoid receptor antagonists SR141716 and SR144528 exhibit properties of partial agonists in experiments on isolated perfused rat heart.

Bulletin of experimental biology and medicine 20050501

Pharmacological modulation of the endocannabinoid system in a viral model of multiple sclerosis.

Journal of neurochemistry 20050301

The nonpsychoactive component of marijuana cannabidiol modulates chemotaxis and IL-10 and IL-12 production of murine macrophages both in vivo and in vitro.

Journal of neuroimmunology 20050201

Endogenous cannabinoid receptor ligand induces the migration of human natural killer cells.

Journal of biochemistry 20050201

Synthetic cannabinoid WIN55,212-2 inhibits generation of inflammatory mediators by IL-1beta-stimulated human astrocytes.

Glia 20050115

Cannabinoids depress excitatory neurotransmission between the subthalamic nucleus and the globus pallidus.

Neuroscience 20050101

Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors.

Brain research. Molecular brain research 20041206

Activation of cannabinoid CB2 receptors suppresses C-fiber responses and windup in spinal wide dynamic range neurons in the absence and presence of inflammation.

Journal of neurophysiology 20041201

New perspectives in the studies on endocannabinoid and cannabis: 2-arachidonoylglycerol as a possible novel mediator of inflammation.

Journal of pharmacological sciences 20041201

Cannabinoid receptor agonists inhibit sensory nerve activation in guinea pig airways.

American journal of respiratory and critical care medicine 20041101

2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, induces the migration of EoL-1 human eosinophilic leukemia cells and human peripheral blood eosinophils.

Journal of leukocyte biology 20041101

Cannabinoid CB2 receptor activation inhibits mechanically evoked responses of wide dynamic range dorsal horn neurons in naïve rats and in rat models of inflammatory and neuropathic pain.

The European journal of neuroscience 20041101

Endocannabinoids acting at cannabinoid-1 receptors regulate cardiovascular function in hypertension.

Circulation 20041005

Characterization of cannabinoid modulation of sensory neurotransmission in the rat isolated mesenteric arterial bed.

The Journal of pharmacology and experimental therapeutics 20041001

The THC-induced suppression of Th1 polarization in response to Legionella pneumophila infection is not mediated by increases in corticosterone and PGE2.

Journal of leukocyte biology 20041001

Vanilloid TRPV1 receptor mediates the antihyperalgesic effect of the nonpsychoactive cannabinoid, cannabidiol, in a rat model of acute inflammation.

British journal of pharmacology 20040901

Cannabinoids inhibit the vascular endothelial growth factor pathway in gliomas.

Cancer research 20040815

Presynaptic cannabinoid CB(1) receptors are involved in the inhibition of the neurogenic vasopressor response during septic shock in pithed rats.

British journal of pharmacology 20040601

Cannabinoid receptor-mediated regulation of intracellular calcium by delta(9)-tetrahydrocannabinol in resting T cells.

Journal of leukocyte biology 20040501

2-Arachidonoylglycerol, an endogenous cannabinoid receptor ligand, induces accelerated production of chemokines in HL-60 cells.

Journal of biochemistry 20040401

Cannabinoid receptors and T helper cells.

Journal of neuroimmunology 20040201

Cannabinoids and the human uterus during pregnancy.

American journal of obstetrics and gynecology 20040101

Inhibitory effect of anandamide on resiniferatoxin-induced sensory neuropeptide release in vivo and neuropathic hyperalgesia in the rat.

Life sciences 20030919

Activation of phosphoinositide 3-kinase/PKB pathway by CB(1) and CB(2) cannabinoid receptors expressed in prostate PC-3 cells. Involvement in Raf-1 stimulation and NGF induction.

Cellular signalling 20030901

Inhibition of guinea-pig and human sensory nerve activity and the cough reflex in guinea-pigs by cannabinoid (CB2) receptor activation.

British journal of pharmacology 20030901

Endogenous interleukin-1 receptor antagonist mediates anti-inflammatory and neuroprotective actions of cannabinoids in neurons and glia.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20030723

Reduction of human monocytic cell neurotoxicity and cytokine secretion by ligands of the cannabinoid-type CB2 receptor.

British journal of pharmacology 20030601

Endocannabinoids protect the rat isolated heart against ischaemia.

British journal of pharmacology 20030601

A cannabinoid agonist differentially attenuates deep tissue hyperalgesia in animal models of cancer and inflammatory muscle pain.

Pain 20030501

Vasodilator actions of abnormal-cannabidiol in rat isolated small mesenteric artery.

British journal of pharmacology 20030401

Pharmacological characterisation of cannabinoid receptors inhibiting interleukin 2 release from human peripheral blood mononuclear cells.

European journal of pharmacology 20030319

Cannabinoids inhibit gap junctional intercellular communication and activate ERK in a rat liver epithelial cell line.

International journal of cancer 20030310

Contribution of endocannabinoids in the endothelial protection afforded by ischemic preconditioning in the isolated rat heart.

Life sciences 20030307

Cannabinoids ablate release of TNFalpha in rat microglial cells stimulated with lypopolysaccharide.

Glia 20030115

Inhibition of interleukin-8 release in the human colonic epithelial cell line HT-29 by cannabinoids.

European journal of pharmacology 20030101

A peripheral cannabinoid mechanism suppresses spinal fos protein expression and pain behavior in a rat model of inflammation.

Neuroscience 20030101

Selective activation of cannabinoid CB(2) receptors suppresses spinal fos protein expression and pain behavior in a rat model of inflammation.

Neuroscience 20030101

The endocannabinoid system protects rat glioma cells against HIV-1 Tat protein-induced cytotoxicity. Mechanism and regulation.

The Journal of biological chemistry 20021227

Delta 9-Tetrahydrocannabinol regulates Th1/Th2 cytokine balance in activated human T cells.

Journal of neuroimmunology 20021201

Anandamide induces cough in conscious guinea-pigs through VR1 receptors.

British journal of pharmacology 20021101

Paradoxical pharmacological effects of deoxy-tetrahydrocannabinol analogs lacking high CB1 receptor affinity.

Pharmacology 20021001

Decrease in efficacy and potency of nonsteroidal anti-inflammatory drugs by chronic delta(9)-tetrahydrocannabinol administration.

The Journal of pharmacology and experimental therapeutics 20021001

SR144528 as inverse agonist of CB2 cannabinoid receptor.

Journal of veterinary science 20020901

Effects of anandamide on embryo implantation in the mouse.

Life sciences 20020823

Endocannabinoids are implicated in the infarct size-reducing effect conferred by heat stress preconditioning in isolated rat hearts.

Cardiovascular research 20020815

Delta(9)-tetrahydrocannabinol-induced apoptosis in the thymus and spleen as a mechanism of immunosuppression in vitro and in vivo.

The Journal of pharmacology and experimental therapeutics 20020801

Attenuation of nerve growth factor-induced visceral hyperalgesia via cannabinoid CB(1) and CB(2)-like receptors.

Pain 20020501

[Increase of the heart arrhythmogenic resistance and decrease of the myocardial necrosis zone during activation of cannabinoid receptors].

Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova 20020501

CB1 and CB2 cannabinoid receptors are implicated in inflammatory pain.

Pain 20020401

Down-regulation by cannabinoids of the immunological activation of human basophils and guinea pig mast cells.

Inflammation research : official journal of the European Histamine Research Society ... [et al.] 20020401

Arvanil-induced inhibition of spasticity and persistent pain: evidence for therapeutic sites of action different from the vanilloid VR1 receptor and cannabinoid CB(1)/CB(2) receptors.

European journal of pharmacology 20020329

Role of CB1 and CB2 receptors in the inhibitory effects of cannabinoids on lipopolysaccharide-induced nitric oxide release in astrocyte cultures.

Journal of neuroscience research 20020315

Effect of the cannabinoid receptor ligand, WIN 55,212-2, on superoxide anion and TNF-alpha production by human mononuclear cells.

International immunopharmacology 20020301

Cannabinol enhancement of interleukin-2 (IL-2) expression by T cells is associated with an increase in IL-2 distal nuclear factor of activated T cell activity.

Molecular pharmacology 20020201

Autocrine and paracrine regulation of lymphocyte CB2 receptor expression by TGF-beta.

Biochemical and biophysical research communications 20020111

Antiinflammatory action of endocannabinoid palmitoylethanolamide and the synthetic cannabinoid nabilone in a model of acute inflammation in the rat.

British journal of pharmacology 20020101

Inhibitory effect of palmitoylethanolamide on gastrointestinal motility in mice.

British journal of pharmacology 20011101

Cannabinoids inhibit nitric oxide production in bone marrow derived feline macrophages.

Veterinary immunology and immunopathology 20011001

Differential effects of anandamide on acetylcholine release in the guinea-pig ileum mediated via vanilloid and non-CB1 cannabinoid receptors.

British journal of pharmacology 20010901

Palmitoylethanolamide inhibits the expression of fatty acid amide hydrolase and enhances the anti-proliferative effect of anandamide in human breast cancer cells.

The Biochemical journal 20010815

Modulation of cytokine responses in Corynebacterium parvum-primed endotoxemic mice by centrally administered cannabinoid ligands.

European journal of pharmacology 20010803

Inhibition of glioma growth in vivo by selective activation of the CB(2) cannabinoid receptor.

Cancer research 20010801

Cannabinoid activation of recombinant and endogenous vanilloid receptors.

European journal of pharmacology 20010727

Antinociceptive activity of the endogenous fatty acid amide, palmitylethanolamide.

European journal of pharmacology 20010511

Cannabinoid inhibition of capsaicin-sensitive sensory neurotransmission in the rat mesenteric arterial bed.

European journal of pharmacology 20010420

Inhibitory effects of SR141716A on G-protein activation in rat brain.

European journal of pharmacology 20010302

Endogenous cannabinoid anandamide increases heart resistance to arrhythmogenic effects of epinephrine: role of CB(1) and CB(2) receptors.

Bulletin of experimental biology and medicine 20010301

Cannabinoids and pain.

Current opinion in investigational drugs (London, England : 2000) 20010301

In vitro and in vivo pharmacological characterization of JTE-907, a novel selective ligand for cannabinoid CB2 receptor.

The Journal of pharmacology and experimental therapeutics 20010201

Human platelets bind and degrade 2-arachidonoylglycerol, which activates these cells through a cannabinoid receptor.

European journal of biochemistry 20010201

Involvement of cannabinoids in the cardioprotection induced by lipopolysaccharide.

British journal of pharmacology 20010201

Cannabinoid CB1-mediated inhibition of stress-induced gastric ulcers in rats.

Naunyn-Schmiedeberg's archives of pharmacology 20010201

Delta-9-tetrahydrocannabinol differentially suppresses cisplatin-induced emesis and indices of motor function via cannabinoid CB(1) receptors in the least shrew.

Pharmacology, biochemistry, and behavior 20010101

Genomic and functional changes induced by the activation of the peripheral cannabinoid receptor CB2 in the promyelocytic cells HL-60. Possible involvement of the CB2 receptor in cell differentiation.

The Journal of biological chemistry 20000526

Cloning and pharmacological characterization of the rat CB(2) cannabinoid receptor.

The Journal of pharmacology and experimental therapeutics 20000301

Evidence that 2-arachidonoylglycerol but not N-palmitoylethanolamine or anandamide is the physiological ligand for the cannabinoid CB2 receptor. Comparison of the agonistic activities of various cannabinoid receptor ligands in HL-60 cells.

The Journal of biological chemistry 20000107

HU-308: a specific agonist for CB(2), a peripheral cannabinoid receptor.

Proceedings of the National Academy of Sciences of the United States of America 19991207

Stimulation of peripheral cannabinoid receptor CB2 induces MCP-1 and IL-8 gene expression in human promyelocytic cell line HL60.

FEBS letters 19990409

Agonist-inverse agonist characterization at CB1 and CB2 cannabinoid receptors of L759633, L759656, and AM630.

British journal of pharmacology 19990201

SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor.

The Journal of pharmacology and experimental therapeutics 19980201